# Ernexa Therapeutics Inc.: Form 8-K, filed Apr 11, 2023

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2023-04-11
- Accepted by EDGAR: Apr 11, 2023, 07:30 ET
- Period: 2023-04-05
- Accession: 0001140361-23-017671
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036123017671/brhc10050812_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036123017671/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036123017671/brhc10050812_8k.htm

Filed Apr 11, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-017671. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.